(Q46916886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Kanako Mochizuki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hirokazu Okumura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Satsuki Ito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yukio Suga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hirohito Yamazaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Masahide Yamazaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yukio Kondo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hidesaku Asakura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shinji Nakao

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

80-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16443558%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1532/ijh97.05111

16 January 2020

exact match

0 references

cites work

Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients

1 reference

12 December 2020

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation

1 reference

12 December 2020

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

1 reference

12 December 2020

Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

1 reference

12 December 2020

Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease

1 reference

12 December 2020

Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease

1 reference

12 December 2020

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

12 December 2020

Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model

1 reference

12 December 2020

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1 reference

12 December 2020

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

1 reference

12 December 2020

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

1 reference

12 December 2020

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

1 reference

12 December 2020

Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

12 December 2020

Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation

1 reference

12 December 2020

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

1 reference

12 December 2020

1994 Consensus Conference on Acute GVHD Grading

1 reference

12 December 2020

Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

Chronic graft-versus-host disease: clinical features and grading systems

1 reference

12 December 2020

Novel strategies for steroid-refractory acute graft-versus-host disease

1 reference

12 December 2020

Diagnosis and clinical management of chronic graft-versus-host disease

1 reference

12 December 2020

Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

1 reference

12 December 2020

Management of acute graft versus host disease (GvHD).

1 reference

12 December 2020

Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant

1 reference

12 December 2020

Graft-versus-host disease: how to translate new insights into new therapeutic strategies

1 reference

12 December 2020

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

1 reference

12 December 2020

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

1 reference

12 December 2020

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

1 reference

12 December 2020